[
  {
    "from_address": "reports@genomadx.com",
    "to_addresses": [
      "ben.carter@synergycr.com"
    ],
    "cc_addresses": [],
    "subject": "ROPAD Study: Genetics Screening Report",
    "timestamp": "2023-11-06T11:00:00Z",
    "body": "Dear Clinical Team,\n\nAttached is the genetics screening batch report (GDX-ROP-23-08) for the ROPAD study, containing results for 5 participants.\n\nThis is an automated notification. Please do not reply to this email.\n\nThank you,\nGenoma Diagnostics Laboratory",
    "attachments": [
      "GDX-ROP-23-08_Screening_Results.pdf"
    ],
    "message_id": 0,
    "in_reply_to": null
  },
  {
    "from_address": "ben.carter@synergycr.com",
    "to_addresses": [
      "alex.johnson@denalitx.com"
    ],
    "cc_addresses": [
      "sarah.chen@denalitx.com"
    ],
    "subject": "Fwd: ROPAD Study: Genetics Screening Report",
    "timestamp": "2023-11-06T15:22:00Z",
    "body": "Hi Alex,\n\nPlease see the attached batch report from Genoma Diagnostics.\n\nThe results indicate two mutation-positive participants (ROP-001-1034 and ROP-002-2011) who are potential candidates for the BIIB122/DNL151 (LIGHTHOUSE) study.\n\nParticipant ROP-002-2011 is located in a country where LIGHTHOUSE is not yet recruiting. Could you please advise on how we should proceed for this individual?\n\nBest regards,\n\nBen Carter\nClinical Research Associate\nSynergy Clinical Research",
    "attachments": [
      "GDX-ROP-23-08_Screening_Results.pdf"
    ],
    "message_id": 1,
    "in_reply_to": 0
  }
]